Aethlon Medical signals expanded Australian oncology enrollment strategy while operating loss narrows to $1.5M (NASDAQ:AEMD)
Aethlon MedicalAethlon Medical(US:AEMD) Seeking Alpha·2025-11-12 23:32

Group 1 - The article does not provide any specific information or data regarding companies or industries [1]